These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 18671743

  • 1. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A, Metaxas A, Yoo JH, McGee T, Kitchen I.
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose "binge" cocaine administration paradigm.
    Bailey A, Gianotti R, Ho A, Kreek MJ.
    Synapse; 2007 Oct; 61(10):820-6. PubMed ID: 17621646
    [Abstract] [Full Text] [Related]

  • 3. Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration.
    Bailey A, Yoo JH, Racz I, Zimmer A, Kitchen I.
    J Neurochem; 2007 Sep; 102(6):1817-1830. PubMed ID: 17532787
    [Abstract] [Full Text] [Related]

  • 4. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration.
    Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1387-96. PubMed ID: 7932193
    [Abstract] [Full Text] [Related]

  • 5. Strain differences in the effects of adrenalectomy on the midbrain dopamine system: implication for behavioral sensitization to cocaine.
    de Jong IE, Steenbergen PJ, de Kloet ER.
    Neuroscience; 2008 May 15; 153(3):594-604. PubMed ID: 18420350
    [Abstract] [Full Text] [Related]

  • 6. Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding.
    Koff JM, Shuster L, Miller LG.
    J Pharmacol Exp Ther; 1994 Jan 15; 268(1):277-82. PubMed ID: 8301568
    [Abstract] [Full Text] [Related]

  • 7. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL, Kopajtic TA, Myers KA, Mitkus RJ, Chider M.
    J Pharmacol Exp Ther; 1999 Oct 15; 291(1):265-79. PubMed ID: 10490913
    [Abstract] [Full Text] [Related]

  • 8. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
    Adlersberg M, Hsiung SC, Glickstein SB, Liu KP, Tamir H, Schmauss C.
    J Neurochem; 2004 Aug 15; 90(4):865-73. PubMed ID: 15287892
    [Abstract] [Full Text] [Related]

  • 9. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
    Chausmer AL, Elmer GI, Rubinstein M, Low MJ, Grandy DK, Katz JL.
    Psychopharmacology (Berl); 2002 Aug 15; 163(1):54-61. PubMed ID: 12185400
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 11. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul 30; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 12. Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids.
    Kunko PM, French D, Izenwasser S.
    J Pharmacol Exp Ther; 1998 Apr 30; 285(1):277-84. PubMed ID: 9536022
    [Abstract] [Full Text] [Related]

  • 13. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.
    Cai G, Wang HY, Friedman E.
    J Pharmacol Exp Ther; 2002 Sep 30; 302(3):1105-12. PubMed ID: 12183669
    [Abstract] [Full Text] [Related]

  • 14. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D, Duterte-Boucher D, Leroux-Nicollet I, Naudon L, Costentin J.
    J Pharmacol Exp Ther; 1996 Jul 30; 278(1):330-7. PubMed ID: 8764367
    [Abstract] [Full Text] [Related]

  • 15. Sex differences in dopamine D2-like receptor-mediated G-protein activation in the medial prefrontal cortex after cocaine.
    Sun WL, Festa ED, Jenab S, Quinones-Jenab V.
    Ethn Dis; 2010 Jul 30; 20(1 Suppl 1):S1-88-91. PubMed ID: 20521392
    [Abstract] [Full Text] [Related]

  • 16. GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
    Yoo JH, Lee HK, Kim HC, Lee SY, Jang CG.
    Synapse; 2010 Apr 30; 64(4):274-9. PubMed ID: 19953653
    [Abstract] [Full Text] [Related]

  • 17. Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins.
    Wang HY, Runyan S, Yadin E, Friedman E.
    J Pharmacol Exp Ther; 1995 Apr 30; 273(1):492-8. PubMed ID: 7714804
    [Abstract] [Full Text] [Related]

  • 18. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A, Eller M, Herm L, Rinken A, Harro J.
    Brain Res; 2007 Feb 02; 1131(1):138-48. PubMed ID: 17156751
    [Abstract] [Full Text] [Related]

  • 19. Genetic influences on drug-induced psychomotor activation in mice.
    Gill KJ, Boyle AE.
    Genes Brain Behav; 2008 Nov 02; 7(8):859-68. PubMed ID: 19076633
    [Abstract] [Full Text] [Related]

  • 20. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
    Varela MJ, Brea J, Loza MI, Maldonado R, Robledo P.
    Behav Pharmacol; 2011 Aug 02; 22(4):362-9. PubMed ID: 21712712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.